The Latest Breaking News from Tandem Diabetes Care

Tandem Diabetes Care Inc.’s (NASDAQ:TNDM) stock plunged on Thursday after the company cut its annual guidance.

A Relative Strength Rating upgrade for Tandem Diabetes Care shows improving technical performance. Will it continue?

Tandem Diabetes Care sees its Relative Strength Rating enter the 80-plus level.

A Relative Strength Rating upgrade for Tandem Diabetes Care shows improving technical performance. Will it continue?

 

Within the last quarter, Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings:

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Over the past 3 months, 4 analysts have published their opinion on Tandem Diabetes Care (NASDAQ:TNDM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM. Here's what investors need to know about the announcement.